Mr Hassan is good at cultural re-engineering: at Pharmacia, he was widely credited with smoothing feathers ruffled by an earlier transatlantic merger and bringing a sense of unity to the firm.
If its sales soar and Merck can't come up with a Zocor replacement, the pressure could mount on Merck and Gilmartin to make Hassan an offer too good to refuse.